Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...
West Bengal is intensifying its focus on pharmaceutical manufacturing as part of a broader industrial development strategy aimed at attracting investment and boosting economic...